The Role of Luteinizing Hormone in Ovarian Stimulation of IVF Programs (literature review)

Rudakova E.B.; Serova O.F.; Strizhova T.V.; Fedorova E.A.; Ostrina S.Ya.

doi:https://doi.org/10.17116/repro202228011129

Close metadata

Recommended articles:

Age-related peculiarities of blood parameters in women and their impact on the outcome of in vitro fertilization programs. Russian Journal of Human Reproduction. 2025;(2):28-36

Visualization of the mitotic spindle in oocytes of patients with ovarian endometriosis as a prognostic factor for the effectiveness of fertilization and early embryonic development in IVF/ICSI programs. Russian Journal of Human Reproduction. 2025;(3):55-62

Influence of carriage of papillomavirus infection on the course of external genital endometriosis in patients with intraepithelial lesion of the cervix. Russian Journal of Human Reproduction. 2025;(3):77-83

Experimental modeling and treatment of endometriosis using bovhyaluronidase azoximer in an animal model. Russian Journal of Human Reproduction. 2025;(4):26-40

The Paternity Test. Russian Journal of Human Reproduction. 2025;(4):41-45

The dependence of the ploidic status of embryos on the state of the spindle of oocyte division, assessed using polarization microscopy in IVF programs in women with ovarian endometriosis. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):44-49

Medical and social characteristics of maternal deaths after extracorporeal fertilization. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):5-14

Primary ovarian insufficiency: opportunities and prospects for the realization of reproductive function. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):42-47

The role of pelvic inflammatory diseases in reproductive function disorders in women. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):48-54

Characteristics of factors contributing to disorders of reproductive function in patients with adenomyosis. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):68-74

Abstract:

The modern data on the importance of the use of gonadotropins containing luteinizing hormone in in vitro fertilization programs are presented. The effect of luteinizing hormone on folliculogenesis and role in ovarian stimulation is described. The advantages of adding LH-active gonadotropins in in vitro fertilization protocols have been evaluated.

Keywords:

in vitro fertilization

infertility

ovarian stimulation

gonadotropins

luteinizing hormone

Authors:

Rudakova E.B.

Moscow Regional Perinatal Center

Serova O.F.

Moscow’s Regional Perinatal Center

Strizhova T.V.

City Clinical Hospital named after D.D. Pletnev of the Health Department

Fedorova E.A.

Moscow Regional Perinatal Center

Ostrina S.Ya.

Moscow Regional Perinatal Centre

ORCID: 0000-0002-3865-8276

Received:

29.12.2021

Accepted:

12.01.2022

Close metadata

References:

Macklon NS, Stouffer RL, Giudice LC, Fauser BC. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocrine Reviews. 2006;27(2):170-207. https://doi.org/10.1210/er.2005-0015
Nazarenko TA, Krasnopol’skaya KV. «Bednyj otvet». Taktika vedeniya pacientok so snizhennoj reakciej na stimulyaciyu gonadotropinami v programmah EKO. M.: MEDpress-inform; 2012. (In Russ.).
Rudakova EB, Zamahovskaya LYu, Strizhova TV, Trubnikova OB, Tatarinova LV. Outcomes of in vitro fertilization as a multifactorial problem of clinical reproductology. Medicinskij Sovet. 2015;9:84-91. (In Russ.). https://doi.org/10.21518/2079-701X-2015-9-84-91
Homburg R. Stimulyaciya yaichnikov. Prakticheskoe rukovodstvo: per. s angl. pod red. Kogana I.Yu. M.: GEOTAR-Media; 2017 (In Russ.).
Vermey BG, Chua SJ, Zafarmand MH, Wang R, Longobardi S, Cottell E, Beckers F, Mol BW, Venetis CA, D’Hooghe T. Is there an association between oocyte number and embryo quality? A systematic review and meta-analysis. Reproductive Biomedicine Online. 2019;39(5):751-763. https://doi.org/10.1016/j.rbmo.2019.06.013
Conforti A, Esteves SC, Cimadomo D, Vaiarelli A, Di Rella F, Ubaldi FM, Zullo F, De Placido G, Alviggi C. Management of Women with an Unexpected Low Ovarian Response to Gonadotropin. Frontiers in Endocrinology. 2019;10:387. https://doi.org/10.3389/fendo.2019.00387
Ata B, Kaplan B, Danzer H, Glassner M, Opsahl M, Tan SL, Munné S. Array CGH analysis shows that aneuploidy is not related to the number of embryos generated. Reproductive Biomedicine Online. 2012;24(6):614-620. https://doi.org/10.1016/j.rbmo.2012.02.009
Kogan IYu, Gzgzyan AM, Lesik EA. Protokoly stimulyacii yaichnikov v ciklah EKO. Rukovodstvo dlya vrachej. M.: GEOTAR-Media; 2017. (In Russ.).
Esteves SC, Carvalho JF, Bento FC, Santos J. A Novel Predictive Model to Estimate the Number of Mature Oocytes Required for Obtaining at Least One Euploid Blastocyst for Transfer in Couples Undergoing in vitro Fertilization/Intracytoplasmic Sperm Injection: The ART Calculator. Frontiers in Endocrinology. 2019;10:99. https://doi.org/10.3389/fendo.2019.00099
Malchau SS, Henningsen AA, Loft A, Rasmussen S, Forman J, Nyboe Andersen A, Pinborg A. The long-term prognosis for live birth in couples initiating fertility treatments. Human Reproduction. 2017; 32(7):1439-1449. https://doi.org/10.1093/humrep/dex096
Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L; ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Human Reproduction. 2011;26(7):1616-1624. https://doi.org/10.1093/humrep/der092
Krasnopol’skaya KV, Nazarenko TA. Klinicheskie aspekty lecheniya besplodiya v brake. Diagnostika i terapevticheskie programmy s ispol’zovaniem metodov vosstanovleniya estestvennoj fertil’nosti i vspomogatel’nyh reproduktivnyh tekhnologij: rukovodstvo. M.: GEOTAR-Media; 2013. (In Russ.).
Nazarenko TA. Stimulyaciya funkcii yaichnikov. 5-e izd., dop. i pererab. M.: MEDpress-inform; 2015. (In Russ.).
Haahr T, Esteves SC, Humaidan P. Individualized controlled ovarian stimulation in expected poor-responders: an update. Reproductive Biology and Endocrinology: RB&E. 2018;16(1):20. https://doi.org/10.1186/s12958-018-0342-1
Bosch E, Alviggi C, Lispi M, Conforti A, Hanyaloglu AC, Chuderland D, Simoni M, Raine-Fenning N, Crépieux P, Kol S, Rochira V, D’Hooghe T, Humaidan P. Reduced FSH and LH action: implications for medically assisted reproduction. Human Reproduction. 2021;36(6):1469-1480. https://doi.org/10.1093/humrep/deab065
Bühler KF, Fischer R. Recombinant human LH supplementation versus supplementation with urinary hCG-based LH activity during controlled ovarian stimulation in the long GnRH-agonist protocol: a matched case-control study. Gynecological Endocrinology. 2012; 28(5):345-350. https://doi.org/10.3109/09513590.2011.633128
Hill MJ, Levens ED, Levy G, Ryan ME, Csokmay JM, DeCherney AH, Whitcomb BW. The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis. Fertility and Sterility. 2012;97(5):1108-1114.e1. https://doi.org/10.1016/j.fertnstert.2012.01.130
Poseidon Group (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number), Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, Esteves SC, Fischer R, Galliano D, Polyzos NP, Sunkara SK, Ubaldi FM, Humaidan P. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertility and Sterility. 2016;105(6):1452-1453. https://doi.org/10.1016/j.fertnstert.2016.02.005
Humaidan P, Alviggi C, Fischer R, Esteves SC. The novel POSEIDON stratification of ‘Low prognosis patients in Assisted Reproductive Technology’ and its proposed marker of successful outcome. F1000Research. 2016;5:2911. https://doi.org/10.12688/f1000research.10382.1
Genro VK, Grynberg M, Scheffer JB, Roux I, Frydman R, Fanchin R. Serum anti-Müllerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation. Human Reproduction. 2011;26(3):671-677. https://doi.org/10.1093/humrep/deq361
Alviggi C, Conforti A, Esteves SC, Vallone R, Venturella R, Staiano S, Castaldo E, Andersen CY, De Placido G. Understanding Ovarian Hypo-Response to Exogenous Gonadotropin in Ovarian Stimulation and Its New Proposed Marker-The Follicle-To-Oocyte (FOI) Index. Frontiers in Endocrinology. 2018;9:589. https://doi.org/10.3389/fendo.2018.00589
Perminova SG. Zhenskoe besplodie i narushenie funkcii shchitovidnoj zhelezy. V kn.: Besplodnyj brak. Sovremennye podhody k diagnostike i lecheniyu: rukovodstvo. Pod. Red. Suhih G.T., Nazarenko T.A. 2-e izd. M.: GEOTAR-Media; 2010. (In Russ.).
Zhordanidze DO. Sostoyanie ovarial’nogo rezerva pri nekotoryh formah besplodiya: Dis. ... kand. med. nauk. 2011. (In Russ.).
Santoro N, Filicori M, Crowley WF Jr. Hypogonadotropic disorders in men and women: diagnosis and therapy with pulsatile gonadotropin-releasing hormone. Endocrine Reviews. 1986;7(1):11-23. https://doi.org/10.1210/edrv-7-1-11
Ghumman S. Principles and Practice of Controlled Ovarian Stimulation in ART. Springer India; 2015. https://doi.org/10.1007/978-81-322-1686-5
Humaidan P, La Marca A, Alviggi C, Esteves SC, Haahr T. Future Perspectives of POSEIDON Stratification for Clinical Practice and Research. Frontiers in Endocrinology. 2019;10:439. https://doi.org/10.3389/fendo.2019.00439
Boehm U, Bouloux PM, Dattani MT, de Roux N, Dodé C, Dunkel L, Dwyer AA, Giacobini P, Hardelin JP, Juul A, Maghnie M, Pitteloud N, Prevot V, Raivio T, Tena-Sempere M, Quinton R, Young J. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism-pathogenesis, diagnosis and treatment. Nature Reviews. Endocrinology. 2015; 11(9):547-564. https://doi.org/10.1038/nrendo.2015.112
Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, Rienzi L, Sunde A, Schmidt L, Cooke ID, Simpson JL, van der Poel S. The International Glossary on Infertility and Fertility Care, 2017. Human Reproduction. 2017;32(9):1786-11801. https://doi.org/10.1093/humrep/dex234
De Placido G, Alviggi C, Perino A, Strina I, Lisi F, Fasolino A, De Palo R, Ranieri A, Colacurci N, Mollo A; Italian Collaborative Group on Recombinant Human Luteinizing Hormone. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Human Reproduction. 2005;20(2):390-396. https://doi.org/10.1093/humrep/deh625
Kol S. Individualized Treatment from Theory to Practice: The Private Case of Adding LH during GnRH Antagonist-based Stimulation Protocol. Clinical Medicine Insights. Reproductive Health. 2014; 8:59-64. https://doi.org/10.4137/CMRH.S17788
Alviggi C, Conforti A, Esteves SC, Andersen CY, Bosch E, Bühler K, Ferraretti AP, De Placido G, Mollo A, Fischer R, Humaidan P; International Collaborative Group for the Study of r-hLH (iCOS-LH). Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review. Fertility and Sterility. 2018;109(4):644-664. https://doi.org/10.1016/j.fertnstert.2018.01.003
Conforti A, Esteves SC, Di Rella F, Strina I, De Rosa P, Fiorenza A, Zullo F, De Placido G, Alviggi C. The role of recombinant LH in women with hypo-response to controlled ovarian stimulation: a systematic review and meta-analysis. Reproductive Biology and Endocrinology: RB&E. 2019;17(1):18. https://doi.org/10.1186/s12958-019-0460-4
Vihko KK, Kujansuu E, Mörsky P, Huhtaniemi I, Punnonen R. Gonadotropins and gonadotropin receptors during the perimenopause. European Journal of Endocrinology. 1996;134(3):357-361. https://doi.org/10.1530/eje.0.1340357
Alviggi C, Clarizia R, Pettersson K, Mollo A, Humaidan P, Strina I, Coppola M, Ranieri A, D’Uva M, De Placido G. Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism. Reproductive Biomedicine Online. 2009;18(1):9-14. https://doi.org/10.1016/s1472-6483(10)60418-x
Alviggi C, Conforti A, Santi D, Esteves SC, Andersen CY, Humaidan P, Chiodini P, De Placido G, Simoni M. Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis. Human Reproduction Update. 2018;24(5):599-614. https://doi.org/10.1093/humupd/dmy019
Wide L, Naessén T, Sundström-Poromaa I, Eriksson K. Sulfonation and sialylation of gonadotropins in women during the menstrual cycle, after menopause, and with polycystic ovarian syndrome and in men. The Journal of Clinical Endocrinology and Metabolism. 2007; 92(11):4410-4417. https://doi.org/10.1210/jc.2007-1342
Riccetti L, De Pascali F, Gilioli L, Santi D, Brigante G, Simoni M, Casarini L. Genetics of gonadotropins and their receptors as markers of ovarian reserve and response in controlled ovarian stimulation. Best Practice and Research. Clinical Obstetrics and Gynaecology. 2017;44:15-25. https://doi.org/10.1016/j.bpobgyn.2017.04.002
Alviggi C, Clarizia R, Mollo A, Ranieri A, De Placido G. Outlook: who needs LH in (ovarian stimulation? Reproductive Biomedicine Online. 2006;12(5):599-607. https://doi.org/10.1016/s1472-6483(10)61186-8
Ruvolo G, Bosco L, Pane A, Morici G, Cittadini E, Roccheri MC. Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures. Fertility and Sterility. 2007;87(3):542-546. https://doi.org/10.1016/j.fertnstert.2006.06.059
Pezzuto A, Ferrari B, Coppola F, Nardelli GB. LH supplementation in down-regulated women undergoing assisted reproduction with baseline low serum LH levels. Gynecological Endocrinology. 2010;26(2):118-124. https://doi.org/10.3109/09513590903215516
Humaidan P, Bungum M, Bungum L, Yding Andersen C. Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study. Reproductive Biomedicine Online. 2004;8(6):635-643. https://doi.org/10.1016/s1472-6483(10)61643-4
Marrs R, Meldrum D, Muasher S, Schoolcraft W, Werlin L, Kelly E. Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment. Reproductive Biomedicine Online. 2004;8(2):175-182. https://doi.org/10.1016/s1472-6483(10)60513-5
Matorras R, Prieto B, Exposito A, Mendoza R, Crisol L, Herranz P, Burgués S. Mid-follicular LH supplementation in women aged 35-39 years undergoing ICSI cycles: a randomized controlled study. Reproductive Biomedicine Online. 2011;22(suppl 1):43-51. https://doi.org/10.1016/S1472-6483(11)60008-4
Bosch E, Labarta E, Crespo J, Simón C, Remohí J, Pellicer A. Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis. Fertility and Sterility. 2011;95(3):1031-1036. https://doi.org/10.1016/j.fertnstert.2010.10.021
Maher JY, Segars J. When is recombinant luteinizing hormone supplementation beneficial during ovarian stimulation? Fertility and Sterility. 2018;109(4):611-612. https://doi.org/10.1016/j.fertnstert.2018.01.041
Borges JE, Braga D, Azevedo M, Iaconelli A, Souza Setti A. Improving implantation rate by adding recombinant LH supplementation to recombinant FSH during controlled ovarian stimulation in GnRH antagonist regimen. Fertility and Sterility. 2019;112(3)e182. https://doi.org/10.1016/j.fertnstert.2019.07.592
Choi J, Smitz J. Luteinizing hormone and human chorionic gonadotropin: origins of difference. Molecular and Cellular Endocrinology. 2014;383(1-2):203-213. https://doi.org/10.1016/j.mce.2013.12.009
Noma N, Kawashima I, Fan HY, Fujita Y, Kawai T, Tomoda Y, Mihara T, Richards JS, Shimada M. LH-induced neuregulin 1 (NRG1) type III transcripts control granulosa cell differentiation and oocyte maturation. Molecular Endocrinology. 2011;25(1):104-116. https://doi.org/10.1210/me.2010-0225
Casarini L, Riccetti L, De Pascali F, Nicoli A, Tagliavini S, Trenti T, La Sala GB, Simoni M. Follicle-stimulating hormone potentiates the steroidogenic activity of chorionic gonadotropin and the anti-apoptotic activity of luteinizing hormone in human granulosa-lutein cells in vitro. Molecular and Cellular Endocrinology. 2016;422: 103-114. https://doi.org/10.1016/j.mce.2015.12.008
Santi D, Casarini L, Alviggi C, Simoni M. Response: Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the «Personalized» Medicine Era: A Meta-analysis. Frontiers in Endocrinology. 2018;9:113. https://doi.org/10.3389/fendo.2018.00113